Results 131 to 140 of about 32,799 (334)
Comparison of hemostatic agents in patients with spontaneous intracerebral hemorrhage
Yujian Li +4 more
openalex +1 more source
V05-05 HEMOSTATIC AGENT STONE: A RARE COMPLICATION OF PERCUTANEOUS NEPHROLITHOTOMY [PDF]
Abdulrahman Ahmad +4 more
openalex +1 more source
Flexible tactile sensors have considerable potential for broad application in healthcare monitoring, human–machine interfaces, and bioinspired robotics. This review explores recent progress in device design, performance optimization, and intelligent applications. It highlights how AI algorithms enhance environmental adaptability and perception accuracy
Siyuan Wang +3 more
wiley +1 more source
Statement of Problem: Hemostatic agents may affect the micro-leakage of different adhesive systems. Also, chlorhexidine has shown positive effects on micro-leakage. However, their interaction effect has not been reported yet. Objectives: To evaluate the
Farhadpour H +3 more
doaj
Aim: The success of pulpotomy depends significantly on the choice of materials and techniques used, including hemostatic agents. Despite extensive research, there remains a lack of consensus on the most effective hemostatic agent for pulpotomy.
Aakash Kumar +5 more
doaj +1 more source
Extramedullary Disease—Achilles Heel in Myeloma?
ABSTRACT Despite advances in therapy, extramedullary disease (EMD) remains an aggressive form of multiple myeloma associated with poor outcomes. Patients with true EMD, in which plasmacytomas have become completely independent of bone, have a particularly poor prognosis. The pathogenesis of EMD is driven by complex mechanisms involving loss of adhesion
Shaji Kumar +7 more
wiley +1 more source
Massive hemorrhage following tissue trauma has high mortality owing to the lack of timely intervention. However, research on utilizing hemostats for humans is limited; therefore, developing an efficient emergency hemostatic agent is imperative.
Jinrun Zhang +12 more
doaj +1 more source
A retrospective cohort study of hemostatic agent use during hysterectomy and risk of post‐operative complications [PDF]
John A. Harris +5 more
openalex +1 more source
ABSTRACT The COMMANDS trial established luspatercept as a first‐line treatment for anemia in transfusion‐dependent lower‐risk (LR) myelodysplastic syndromes (MDS). Here we report red blood cell (RBC) transfusion response analysis based on somatic mutations profile and disease risk for patients treated with luspatercept or epoetin alfa in the COMMANDS ...
Rami S. Komrokji +9 more
wiley +1 more source

